Examining outcomes in STEMI patients with cardiogenic shock in Abu Dhabi
Clinical Characteristics and Outcomes Among ST-elevation Myocardial Infarction (STEMI) Patients With Cardiogenic Shock at Abu Dhabi City
This study looks at the health outcomes of patients in Abu Dhabi who had a serious heart attack complicated by shock to see how different treatments and patient factors affect their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Abu Dhabi Health Services Company Government |
| Locations | 2 sites (Abu Dhabi, Abu Dhabi Emirate and 1 other locations) |
| Trial ID | NCT06535503 on ClinicalTrials.gov |
What this trial studies
This observational study analyzes the clinical characteristics and treatment outcomes of patients who experienced ST-elevation Myocardial Infarction (STEMI) complicated by cardiogenic shock (CS) at two major hospitals in Abu Dhabi, UAE, from 2020 to 2024. By reviewing electronic medical records, the study aims to identify treatment trends, hospitalization events, and patient demographics that influence recovery or mortality rates. The research addresses the high mortality rates associated with cardiovascular disease in the UAE and seeks to fill gaps in existing knowledge regarding STEMI and CS in the region.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 who were hospitalized for STEMI complicated by cardiogenic shock at the participating hospitals.
Not a fit: Patients under 18 or those with cardiogenic shock not related to myocardial infarction will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve understanding of treatment outcomes for STEMI patients with cardiogenic shock, potentially leading to better management strategies.
How similar studies have performed: While there is limited research specifically on this population in the UAE, similar studies in other regions have shown success in identifying treatment outcomes for STEMI patients with cardiogenic shock.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age more than 18. * STEMI complicated by cardiogenic shock. * Were hospitalized or treated at SSMC or SKMC for STEMI complicated by cardiogenic shock. * Patient admitted between January 2019 to March 2024. Exclusion Criteria: * Age less than 18. * Shock patient not related to Myocardial infarction. * NSTEMI-related cardiogenic shock. * Patients who were not treated at SSMC or SKMC for the STEMI complicated by cardiogenic shock. * Patient not admitted between January 2019 to March 2024.
Where this trial is running
Abu Dhabi, Abu Dhabi Emirate and 1 other locations
- Sheikh Khalifa Medical City (SKMC) — Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates (Recruiting)
- Sheikh Shakhbout Medical City (SKMC) — Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates (Recruiting)
Study contacts
- Principal investigator: Babiker Babiker Mohamed Babiker Elsiraj MB Elsiraj — Sheikh Shakhbout Medical City
- Study coordinator: Alina Naeem, MBBS
- Email: alnaeem@seha.ae
- Phone: 0097124102534
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.